Results 231 to 240 of about 15,140 (255)
Some of the next articles are maybe not open access.
Terbinafine-associated hepatic injury
Journal of Hepatology, 1994We describe two cases of terbinafine-associated hepatic injury, in which a mixed cholestatic-hepatocellular type of hepatitis was present. In both cases extrahepatic cholestasis and viral hepatitis were excluded and involvement of other drugs was unlikely.
Bruno H. Stricker +3 more
openaire +3 more sources
Journal of dermatological treatment (Print), 2019
Background: There has been an alarming increase in recalcitrant dermatophytosis in recent years. The standard treatment guidelines no longer seem effective in achieving clearance and results in high failure rates.
Priyanka Sharma +3 more
semanticscholar +1 more source
Background: There has been an alarming increase in recalcitrant dermatophytosis in recent years. The standard treatment guidelines no longer seem effective in achieving clearance and results in high failure rates.
Priyanka Sharma +3 more
semanticscholar +1 more source
Interaction between Terbinafine and Warfarin
Dermatology, 1998A 71-year-old woman presented with gastrointestinal bleeding. She had been stabilized on warfarin for the previous few months. Terbinafine had been started 32 days prior to this episode for the treatment of onychomycosis. The patient had been on cimetidine for the previous 2 years and on other medications for the last 10 years. At the time of admission
G.S. Ross, Aditya K. Gupta
openaire +3 more sources
Erroneous substitution of terbinafine for lamotrigine
Neurology, 1997Inadvertent substitutions of one pharmaceutical agent for another are frequently reported for many medications, including antiepileptic drugs. Occasionally, serious adverse effects have resulted from such dispensing errors. Multiple causes exist for these mistakes: two medications can have similar generic or brand names, tablets made by one ...
openaire +2 more sources
Terbinafine: a pharmacological and clinical review
Expert Opinion on Pharmacotherapy, 2009Terbinafine (TRB) is an allylamine antifungal agent that has been available for more than a decade. It is now used for the treatment of dermatophytic infections and onychomycosis. Despite several studies having demonstrated the efficacy of terbinafine against nondermatophytic infections including azole-resistant candidiasis, invasive aspergillosis ...
openaire +2 more sources